Presentation at Mello2025
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SVNS notes
Solvonis Therapeutics plc (LSE: SVNS), a clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders, is pleased to announce that the Company will be presenting at the Mello2025 investor event on Tuesday 3rd June 2025, to be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY. Anthony Tennyson, CEO, will be presenting and will take questions during the event.
| www.solvonis.com | X (formerly Twitter) |
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.